Tianjin Medical University (TMU) (Chinese: 天津医科大学; pinyin: Tiānjīn Yīkē Dàxué) was founded in 1951; was the first medical institution approved by the State Council of the People’s Republic of China. Hsien-I Chu, a renowned endocrinologist, was the first president of the university. The current president is Shang Yongfeng.
In December 1993, with the approval of the State Education Council, the Tianjin Medical College and the Tianjin Second Medical College were integrated into the Tianjin Medical University. In December 1996, the university was accepted into Project 211, becoming one of the 97 key institutions (9 medical institutions) given development priority by the State. It is a Chinese state Double First Class University, included in the Double First Class University Plan identified by the Ministry of Education. In 1981, the university was approved by the Academic Degree Committee of State Council to confer the Doctorate Degree, Master’s Degree and Bachelor’s Degree and in 1988, was permitted to set up seven-year medical program.
It is listed in International Medical Education Directory (IMED).
The University has a number of State-level Key Disciplines and Local-level Key Disciplines. The Clinical Integration of Traditional Chinese medicine and Western Medicine (Surgery) is a State-level Key Discipline. The eight Local-level Key Disciplines are Endocrinology and Metabolic Disease, Oncology, Neurology, Medical Imaging, Urinary Surgery, Cardiovascular Diseases, Nuclear Medicine and General Surgery. Three Local-level Key Development Disciplines are Microbiology and Immunology, Ophthalmology and Stomatology. The University has nine Research Institutions, one Key Laboratory of Ministry of Health and nine Clinical Pharmacology Center of Ministry of Health. Over the recent ten years, about three hundred medical researches passed the appraisals and eleven researches won the national awards.